vs

Side-by-side financial comparison of GLAUKOS Corp (GKOS) and VARONIS SYSTEMS INC (VRNS). Click either name above to swap in a different company.

VARONIS SYSTEMS INC is the larger business by last-quarter revenue ($173.1M vs $150.6M, roughly 1.1× GLAUKOS Corp). On growth, GLAUKOS Corp posted the faster year-over-year revenue change (41.2% vs 26.9%). Over the past eight quarters, GLAUKOS Corp's revenue compounded faster (25.4% CAGR vs 15.2%).

Glaukos Corp is a medical technology company focused on ophthalmology, developing and commercializing minimally invasive surgical devices, prescription pharmaceuticals and consumer products for glaucoma, corneal diseases and other eye disorders. It operates primarily across North America, Europe and Asia Pacific, serving hospitals, ophthalmology clinics and patients worldwide.

Varonis Systems, Inc. is a software company based in Miami, Florida with R&D offices in Herzliya, Israel. The company’s Data Security Platform analyzes data and data activity using the insights to identify data exposure risks stemming from access permissions and software-as-a-service (SaaS) app configurations, triggering automated remediation capabilities in response.

GKOS vs VRNS — Head-to-Head

Bigger by revenue
VRNS
VRNS
1.1× larger
VRNS
$173.1M
$150.6M
GKOS
Growing faster (revenue YoY)
GKOS
GKOS
+14.3% gap
GKOS
41.2%
26.9%
VRNS
Faster 2-yr revenue CAGR
GKOS
GKOS
Annualised
GKOS
25.4%
15.2%
VRNS

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
GKOS
GKOS
VRNS
VRNS
Revenue
$150.6M
$173.1M
Net Profit
$9.4M
Gross Margin
77.9%
76.0%
Operating Margin
9.0%
-1.7%
Net Margin
6.2%
Revenue YoY
41.2%
26.9%
Net Profit YoY
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GKOS
GKOS
VRNS
VRNS
Q1 26
$150.6M
$173.1M
Q4 25
$143.1M
$173.4M
Q3 25
$133.5M
$161.6M
Q2 25
$124.1M
$152.2M
Q1 25
$106.7M
$136.4M
Q4 24
$105.5M
$158.5M
Q3 24
$96.7M
$148.1M
Q2 24
$95.7M
$130.3M
Net Profit
GKOS
GKOS
VRNS
VRNS
Q1 26
$9.4M
Q4 25
$-133.7M
$-27.8M
Q3 25
$-16.2M
$-29.9M
Q2 25
$-19.7M
$-35.8M
Q1 25
$-18.1M
$-35.8M
Q4 24
$-33.6M
$-13.0M
Q3 24
$-21.4M
$-18.3M
Q2 24
$-50.5M
$-23.9M
Gross Margin
GKOS
GKOS
VRNS
VRNS
Q1 26
77.9%
76.0%
Q4 25
-1.1%
78.9%
Q3 25
78.4%
78.2%
Q2 25
78.3%
79.5%
Q1 25
77.2%
78.7%
Q4 24
72.9%
83.6%
Q3 24
76.6%
83.8%
Q2 24
76.4%
82.8%
Operating Margin
GKOS
GKOS
VRNS
VRNS
Q1 26
9.0%
-1.7%
Q4 25
-97.7%
-17.5%
Q3 25
-12.3%
-22.2%
Q2 25
-18.3%
-24.0%
Q1 25
-19.4%
-32.1%
Q4 24
-27.2%
-11.1%
Q3 24
-25.5%
-16.0%
Q2 24
-31.3%
-22.1%
Net Margin
GKOS
GKOS
VRNS
VRNS
Q1 26
6.2%
Q4 25
-93.4%
-16.0%
Q3 25
-12.2%
-18.5%
Q2 25
-15.8%
-23.5%
Q1 25
-17.0%
-26.2%
Q4 24
-31.8%
-8.2%
Q3 24
-22.1%
-12.4%
Q2 24
-52.8%
-18.4%
EPS (diluted)
GKOS
GKOS
VRNS
VRNS
Q1 26
Q4 25
$-2.34
$-0.23
Q3 25
$-0.28
$-0.26
Q2 25
$-0.34
$-0.32
Q1 25
$-0.32
$-0.32
Q4 24
$-0.56
$-0.12
Q3 24
$-0.39
$-0.16
Q2 24
$-1.00
$-0.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GKOS
GKOS
VRNS
VRNS
Cash + ST InvestmentsLiquidity on hand
$276.7M
$179.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$670.9M
$453.5M
Total Assets
$893.3M
$1.6B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GKOS
GKOS
VRNS
VRNS
Q1 26
$276.7M
$179.3M
Q4 25
$90.8M
$883.7M
Q3 25
$98.2M
$671.3M
Q2 25
$100.8M
$770.9M
Q1 25
$114.3M
$567.6M
Q4 24
$169.6M
$529.0M
Q3 24
$100.1M
$844.8M
Q2 24
$68.1M
$582.5M
Stockholders' Equity
GKOS
GKOS
VRNS
VRNS
Q1 26
$670.9M
$453.5M
Q4 25
$656.2M
$598.7M
Q3 25
$769.5M
$604.8M
Q2 25
$765.1M
$341.5M
Q1 25
$764.0M
$367.7M
Q4 24
$766.9M
$455.7M
Q3 24
$668.5M
$428.6M
Q2 24
$665.2M
$458.6M
Total Assets
GKOS
GKOS
VRNS
VRNS
Q1 26
$893.3M
$1.6B
Q4 25
$893.5M
$1.8B
Q3 25
$999.4M
$1.7B
Q2 25
$987.0M
$1.6B
Q1 25
$966.2M
$1.6B
Q4 24
$974.8M
$1.7B
Q3 24
$926.5M
$1.5B
Q2 24
$919.7M
$1.1B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GKOS
GKOS
VRNS
VRNS
Operating Cash FlowLast quarter
$55.0M
Free Cash FlowOCF − Capex
$49.0M
FCF MarginFCF / Revenue
28.3%
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$118.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GKOS
GKOS
VRNS
VRNS
Q1 26
$55.0M
Q4 25
$6.8M
$24.7M
Q3 25
$-10.1M
$33.4M
Q2 25
$7.0M
$21.3M
Q1 25
$-18.5M
$68.0M
Q4 24
$507.0K
$24.3M
Q3 24
$-9.6M
$22.5M
Q2 24
$-18.4M
$11.7M
Free Cash Flow
GKOS
GKOS
VRNS
VRNS
Q1 26
$49.0M
Q4 25
$3.9M
$20.7M
Q3 25
$-11.7M
$30.4M
Q2 25
$5.8M
$18.0M
Q1 25
$-20.5M
$65.7M
Q4 24
$-1.2M
$19.9M
Q3 24
$-11.0M
$21.3M
Q2 24
$-20.5M
$10.9M
FCF Margin
GKOS
GKOS
VRNS
VRNS
Q1 26
28.3%
Q4 25
2.7%
12.0%
Q3 25
-8.8%
18.8%
Q2 25
4.7%
11.8%
Q1 25
-19.2%
48.1%
Q4 24
-1.2%
12.6%
Q3 24
-11.4%
14.4%
Q2 24
-21.4%
8.4%
Capex Intensity
GKOS
GKOS
VRNS
VRNS
Q1 26
Q4 25
2.0%
2.3%
Q3 25
1.2%
1.8%
Q2 25
0.9%
2.2%
Q1 25
1.8%
1.7%
Q4 24
1.6%
2.7%
Q3 24
1.5%
0.8%
Q2 24
2.2%
0.6%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GKOS
GKOS

Segment breakdown not available.

VRNS
VRNS

SaaS$161.1M93%
Term license subscriptions$6.9M4%
Maintenance and services$5.2M3%

Related Comparisons